Supersensitive response to isoproterenol in patients with marked global reduction of cardiac metaiodobenzylguanidine uptake

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

It is unknown whether the non-transplanted, denervated human heart is supersensitive to β-adrenergic agonist in terms of inotropism and chronotropism. In the present study, 36 patients with normal left ventricular (LV) wall motion were divided into 3 groups according to the cardiac metaiodobenzylguanidine (MIBG) scintigrams: group I with normal MIBG uptake, group II with regionally reduced MIBG uptake, and group III with globally reduced MIBG uptake (heart-to-mediastinum ratio <1.6). Before isoproterenol (IP) infusion, heart rate (HR), blood pressure (BP) and echocardiographic indices were similar among the groups. There was a trend toward a greater increase in HR with IP (0.01μg·kg-1. min-1) in group III (27±18 beats/min) than in groups I (20±8) and II (17±8) despite the lack of a significant difference in BP reduction by IP. During IP infusion, increases in posterior wall motion amplitude and LV fractional shortening were significantly greater in group III (4.5±1.8 mm and 16.4±5.4%, respectively) than in groups I (1.5±2.5 mm and 8.7±6.4%) and 11 (2.6±1.7 mm and 8.9±7.9%). The present results suggest that the sympathetically denervated human heart is supersensitive to IP and the exaggerated responses may be caused, at least in part, by a postsynaptic mechanism.

Cite

CITATION STYLE

APA

Yoshida, N., Nozawa, T., Nonomura, M., Igarashi, N., Kato, B. I., Fujii, N., … Inoue, H. (2003). Supersensitive response to isoproterenol in patients with marked global reduction of cardiac metaiodobenzylguanidine uptake. Circulation Journal, 67(9), 745–749. https://doi.org/10.1253/circj.67.745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free